| Cover | Jun. 13, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Jun. 13, 2024 |
| Entity File Number | 001-36332 |
| Entity Registrant Name | ALDEYRA THERAPEUTICS, INC. |
| Entity Central Index Key | 0001341235 |
| Entity Tax Identification Number | 20-1968197 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 131 Hartwell Avenue |
| Entity Address, Address Line Two | Suite 320 |
| Entity Address, City or Town | Lexington |
| Entity Address, State or Province | MA |
| Entity Address, Postal Zip Code | 02421 |
| City Area Code | 781 |
| Local Phone Number | 761-4904 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.001 par value per share |
| Trading Symbol | ALDX |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
